Mabel Chan
About Mabel Chan
Mabel Chan is a scientist with a strong background in immunology, currently working at Asher Biotherapeutics since 2021. She previously held postdoctoral positions at UCSF and UC Berkeley and earned her Ph.D. in Immunology from The University of Tokyo.
Work at Asher Biotherapeutics
Mabel Chan has been employed at Asher Biotherapeutics as a Scientist since 2021. In this role, she applies her extensive knowledge and skills in immunology and life sciences to contribute to the development of innovative biotherapeutic solutions. Her work focuses on advancing research in areas related to infection, inflammation, autoimmunity, metabolism, and oncology.
Previous Experience at UCSF
Prior to her current position, Mabel Chan worked as a Postdoctoral Fellow at the University of California, San Francisco (UCSF) from 2016 to 2021. During her five years at UCSF, she engaged in significant research projects that enhanced her expertise in immunology and related fields. This experience provided her with a strong foundation in scientific research methodologies.
Education and Expertise
Mabel Chan earned her Doctor of Philosophy (Ph.D.) in Immunology from The University of Tokyo, where she studied from 2010 to 2014. She also studied at The University of Hong Kong, further developing her academic background. Her advanced skills include Flow Cytometry, Microscopy, Genetics, and Cell Biology, which complement her research interests in various biological processes.
Postdoctoral Scholar at UC Berkeley
Before her tenure at UCSF, Mabel Chan served as a Postdoctoral Scholar at the University of California, Berkeley, from 2015 to 2016. This one-year position allowed her to deepen her research capabilities and broaden her understanding of immunological concepts, contributing to her overall scientific development.
Research Background in Immunology
Mabel Chan possesses a strong research background in immunology, focusing on critical areas such as infection, inflammation, autoimmunity, metabolism, and oncology. Her extensive training and experience in these fields enable her to conduct impactful research and contribute to advancements in biotherapeutics.